Fozia Ahmed

Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity

Mikhail Kosiborod, Steen Z. Abildstrøm, Barry A. Borlaug et al. · New England Journal of Medicine · 2023 · 1.2K citations · Full text

Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes

Mikhail Kosiborod, Mark C. Petrie, Barry A. Borlaug et al. · New England Journal of Medicine · 2024 · 520 citations · Full text

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Paul R. Kalra, John G.F. Cleland, Mark C. Petrie et al. · The Lancet · 2022 · 344 citations · Full text

Heart Failure, Intravenous Ferric Derisomaltose, Iron Metabolism +3

Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials

Javed Butler, Sanjiv J. Shah, Mark C. Petrie et al. · The Lancet · 2024 · 275 citations · Full text

Obesity, Metabolic Syndrome, Non-pharmacological Intervention +15

Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial

Gavin A. Lewis, Susanna Dodd, Dannii Clayton et al. · Nature Medicine · 2021 · 181 citations · Full text

Heart Failure, Cardiogenic Shock, Cardiovascular Disease +9